PROCEPT BioRobotics Corporation Earnings Per Share (Basic)
PROCEPT BioRobotics Corporation (PRCT) reported Earnings Per Share (Basic) of -$0.47 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- PROCEPT BioRobotics Corporation earnings per share, basic for the quarter ending 2026-06-30 was -$0.47.
- PROCEPT BioRobotics Corporation earnings per share, basic for the quarter ending 2026-03-31 was -$0.56.
- PROCEPT BioRobotics Corporation earnings per share, basic for the quarter ending 2025-12-31 was $1.17, a 13.03% decline year-over-year.
- PROCEPT BioRobotics Corporation earnings per share, basic for the quarter ending 2025-09-30 was -$0.38.
- PROCEPT BioRobotics Corporation earnings per share, basic for fiscal 2025 was -$1.72.
- PROCEPT BioRobotics Corporation earnings per share, basic for fiscal 2024 was -$1.75.
- PROCEPT BioRobotics Corporation earnings per share, basic for fiscal 2023 was -$2.24.
- PROCEPT BioRobotics Corporation earnings per share, basic for fiscal 2022 was -$1.96.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.47 10-Q · filed 2026-08-05 | -$1.03 10-Q · filed 2026-08-05 | $0.13 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.56 10-Q · filed 2026-04-30 | $0.60 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.22 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $1.17 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.79 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.44 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.72 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.38 10-Q · filed 2025-11-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.19 10-Q · filed 2025-11-05 | $0.12 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.35 10-Q · filed 2026-08-05 | -$0.80 10-Q · filed 2026-08-05 | $0.51 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.13 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.45 10-Q · filed 2026-04-30 | $0.88 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.50 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.02 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | $1.35 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.97 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.49 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.75 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.40 10-Q · filed 2025-11-05 | -$0.90 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.41 10-Q · filed 2025-11-05 | $0.11 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-06-30 | -$0.50 10-Q · filed 2025-08-07 | -$1.01 10-Q · filed 2025-08-07 | $0.52 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.04 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-03-31 | -$0.51 10-Q · filed 2025-05-02 | $1.03 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.55 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.05 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-12-31 | $1.55 derived: net income ÷ weighted average shares · filed 2026-04-22 | $1.08 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.59 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.24 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.51 10-Q · filed 2024-10-28 | -$1.07 derived: net income ÷ weighted average shares · filed 2024-10-28 | -$1.70 10-Q · filed 2024-10-28 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-06-30 | -$0.56 10-Q · filed 2024-08-02 | -$1.19 10-Q · filed 2024-08-02 | $0.11 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-02 | $0.68 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.17 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2022-12-31 | $1.32 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.81 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.38 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.96 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.51 10-Q · filed 2023-11-02 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.33 10-Q · filed 2023-11-02 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2022-06-30 | -$0.43 10-Q · filed 2023-07-28 | -$0.82 10-Q · filed 2023-07-28 | $0.12 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2022-03-31 | -$0.39 10-Q · filed 2023-05-04 | $0.55 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.31 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2021-12-31 | $0.95 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.99 derived: net income ÷ weighted average shares · filed 2026-04-22 | $0.63 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$3.63 10-K · filed 2024-02-28 |
| 2021-09-30 | -$1.22 10-Q · filed 2022-11-04 | -$3.34 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$5.64 10-Q · filed 2022-11-04 | -$8.51 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2021-06-30 | -$2.60 10-Q · filed 2022-08-05 | -$5.25 10-Q · filed 2022-08-05 | -$8.48 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$11.26 derived: net income ÷ weighted average shares · filed 2022-11-04 |
| 2021-03-31 | -$2.65 10-Q · filed 2022-05-06 | -$5.92 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$8.70 derived: net income ÷ weighted average shares · filed 2022-11-04 | |
| 2020-12-31 | -$3.27 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$6.06 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$14.47 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$2.77 10-Q · filed 2021-11-05 | -$11.34 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |